Press What’s news at AbelsonTaylor Group
Select category
At the top of their game: Pinnacle Award honorees announced
MM+M salutes the 19 honorees of its inaugural Pinnacle Awards for their continuing leadership and lasting impact on the health industry.
April 21, 2021
Dale Taylor, CEO, AbelsonTaylor
Over the 40 years that Dale Taylor has led AbelsonTaylor, the agency has grown from 15 employees to several hundred and has been instrumental in turning Prevacid, Neupogen, Aranesp, Neulasta, Tarceva, Similac and other products into megabrands. Taylor’s view of clients as partners in valued relationships — as opposed to mere revenue streams — is a large part of why he is such a respected figure in the agency world. He similarly treats his colleagues and employees with empathy and respect. “Dale cares about the talent at his agency — how they perceive him and his word,” says Tom Harrison, chairman emeritus of Omnicom’s Diversified Agency Services group.
Colleagues cite “curiosity” and “joy” as central elements of Taylor’s leadership style and say he uses both to encourage intelligent, creative work. And pre-COVID, Taylor still walked the office halls daily, even after four decades.
Media Contact:
Recent Posts
Prioritizing Mental Health
Prioritizing mental well-being can transform lives and careers. Read VP, Account Director Jeremy Vannatta’s story in the March 2025 mental...
In the News Read more Prioritizing Mental HealthNavigating a Cookieless Future: What Pharma Marketers Need to Know
Senior Director of Performance Media Mike D’Orazio shares his thoughts on how pharma marketers can deliver targeted advertising as an...
In the News Read more Navigating a Cookieless Future: What Pharma Marketers Need to KnowAgenda 2025: A New Frontier
In MedAdNews’ “Agenda 2025: A New Frontier,” AbelsonTaylor Group leaders discuss what’s on the horizon for medical advertising in light...
Read Press Read more Agenda 2025: A New FrontierConnect with us
Find out what's top of mind for the people reimagining health and wellness advertising.